PSA-IP - Viking Electronics, Inc.
PDF) The possibilities of age reference values of PSA density in prostatic cancer screening
Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging: Efficient Threshold or Legacy of the Past? - European Urology Focus
Serum PSA levels, prostate volume, and SNPs in PSA promoter region | Download Scientific Diagram
PSA Testing | ZERO Prostate Cancer
Tissue PSA distribution across the prostate gland at t = 0.5 y, tumor... | Download Scientific Diagram
Three-month early change in prostate-specific antigen levels as a predictive marker for overall survival during hormonal therapy for metastatic hormone-sensitive prostate cancer | BMC Research Notes | Full Text
Frontiers | Evaluation and multi-institutional validation of a novel urine biomarker lncRNA546 to improve the diagnostic specificity of prostate cancer in PSA gray-zone
Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study
Detection of recurrent prostate cancer with 18F-fluorocholine PET/CT in relation to PSA level at the time of imaging | SpringerLink
Frontiers | Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy
Changes in PSA after one year of TRT | Download Table
Understanding PSA Levels & The PSA Test | HALO Precision Diagnostics
PSA Test stock photo. Image of cell, prostate, medical - 54017994
Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) Significantly Improve Prostate Cancer Detection at Initial Biopsy in a Total PSA Range of 2–10 ng/ml | PLOS ONE
Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology
Incorporating Known Genetic Variants Does Not Improve the Accuracy of PSA Testing to Identify High Risk Prostate Cancer on Biopsy | PLOS ONE
